Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Colorectal Neoplasms 12Breast Neoplasms 11Lung Neoplasms 9Uterine Cervical Neoplasms 8Neoplasms 8Colonic Neoplasms 5Hematopoietic and Lymphatic System Neoplasm 4Papillomavirus Infections 3Liver Neoplasms 3Carcinoma, Hepatocellular 3Rectal Neoplasms 2Prostatic Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Patient Compliance 2Neoplasm Metastasis 2Hematologic Neoplasms 2Colorectal Cancer Screening 2Tobacco Use 1Smoking 1Pyloric Stenosis, Hypertrophic 1Psychological Well-Being 1Overweight 1Obesity 1Multiple Myeloma 1Multiple Endocrine Neoplasia Type 1 1Lymphoma 1Liver Diseases 1Hypertension 1Hepatitis C 1Head and Neck Neoplasms 1

Interventions

Sorafenib 202lenvatinib 129Bevacizumab 125Nivolumab 84pembrolizumab 72atezolizumab 72Radiosurgery 71durvalumab 63Oxaliplatin 59sintilimab 57Fluorouracil 54Doxorubicin 44tislelizumab 43apatinib 42Leucovorin 40tremelimumab 37Radiofrequency Ablation 37camrelizumab 36Radiotherapy 36Magnetic Resonance Spectroscopy 32Capecitabine 30regorafenib 29Folfox protocol 29Cisplatin 28Hepatectomy 26Gemcitabine 26Cyclophosphamide 26cabozantinib 25Ipilimumab 25toripalimab 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Carcinoma, Hepatocellular × Patient Navigation × Clear all
NCT07568457 2026-05-05

Social Determinants of Health HCC Trial

University of Southern California

Phase NA Not yet recruiting
75 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02312817 2025-07-15

RCT of Screening Strategies Among Patients at High Risk for Developing HCC in a Safety-net Health System

University of Texas Southwestern Medical Center

Phase NA Completed
1,800 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms

NCT02833298 2018-10-12

Post Sustained Virological Response (SVR) Hepatocellular Carcinoma (HCC) Screening

Icahn School of Medicine at Mount Sinai

Phase NA Completed
25 enrolled
Gastrointestinal

Hepatitis C, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡